Remove Containment Remove Sales Remove Trials
article thumbnail

New Anti-Hangover Pill Claims to Rapidly Break Down Alcohol, But Does It Work?

AuroBlog - Aurous Healthcare Clinical Trials blog

A new anti-hangover supplement has just gone on sale in the UK. This means that if someone drinks 50 ml of 40 percent spirits, which contains […]. It is marketed by Swedish firm Myrkl as “the pre-drinking pill that works” The pill is said to break down up to 70 percent of alcohol after 60 minutes.

article thumbnail

STAT+: Mirati wins FDA approval for KRAS-blocking lung cancer drug, but blockbuster sales hopes have dimmed

STAT News

However, hopes the drug might reach a large swath of patients — and grow into a commercial blockbuster for its maker Mirati Therapeutics — have dimmed in the wake of underwhelming clinical trial results. The mutation is found in approximately 13% of lung tumors. Continue to STAT+ to read the full story…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CSL doses first patient with haemophilia B gene therapy Hemgenix

Pharmaceutical Technology

This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891). Hemgenix works by dosing a patient with an engineered adeno-associated virus (AAV), containing the gene responsible for producing a protein called factor IX. Haemophilia B is a rare condition.

article thumbnail

Kite and Arcellx enter partnership for multiple myeloma therapy development

Pharmaceutical Technology

An investigational late-stage product candidate, CART-ddBCMA is being analysed in the Phase II iMMagine-1 clinical trial at present. It leverages the new D-Domain binder of Arcellx and contains autologous T cells genetically modified for targeting multiple myeloma. Additionally, Kite will make other potential payments to Arcellx.

article thumbnail

Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales

XTalks

Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? But if you thought the growing number of patients presenting with mask-associated dry eye would mean higher sales for Restasis, think again.

Sales 119
article thumbnail

P360 Adds Advanced Artificial Intelligence Capabilities to its Sales Enablement Platform BirdzAI

pharmaphorum

Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . P360 , a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI. Partnering with P360 has allowed us to do just that.

Sales 71
article thumbnail

Leading clinical dose companies in contract marketing

Pharmaceutical Technology

The growing clinical trial market is increasing the need for efficient clinical dose contract manufacturing and marketing capabilities to achieve technical and commercial goals. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.

Marketing 100